The Effects of COVID-19 on Patient Experience and Price Transparency
Ogi Kwon, of R1 Revenue Cycle Management (RCM) offers insights on lessons learned from the COVID-19 pandemic and the future of price transparency.
The COVID-19 pandemic provides an opportunity for organizations to think about how they can be proactive and monitor new regulatory changes in real time, said Ogi Kwon, a manager in the regulatory team at R1 RCM's advisory and assurance department.
In this interview with Chief Healthcare Executive™, Kwon explains how he feels price transparency as a whole while be something that continues to be iterated upon going forward and how requirements could take different forms.
R1 RCM is a revenue cycle management company that offers technology-driven solutions to transform health care providers' patient experience and financial performance.
Healthcare leaders: Prepare for a very different HIPAA security rule | Viewpoint
April 20th 2025The proposed changes to the HIPAA Security Rule are significant. Executives and boards need to prepare as the days of voluntary compliance end and a new era where leaders are held personally accountable emerges.
